Attack Risk

March 16, 2015 4:18 PM

17 15

Attack Risk

SAN DIEGO—Researchers reported the first evidence that a new class of drugs known to dramatically lower cholesterol may also reduce risk of heart attacks, strokes and other serious consequences of cardiovascular disease.

The reports, from relatively small studies sponsored by Amgen Inc. and by Sanofi SA and its partner Regeneron Pharmaceuticals Inc., found that the drugs cut risk of major cardiovascular events by about half.

Read more

To category page